WCG Biosafety™ aligns the leading authorities in biosafety, biosecurity, and bio-risk management to provide comprehensive review services and consulting solutions to institutions around the world, helping them to ensure the protection of human subjects, the safety of their investigators and personnel, and the security of their laboratories and workspaces.
The most experienced and trusted provider of Biosafety solutions, the WIRB-Copernicus Group® (WCG) has evaluated over 350 human gene transfer protocols to date – more than any organization outside of the Food and Drug Administration (FDA) and the National Institute of Health (NIH). We also maintain a global presence, operating Institutional Biosafety Committees (IBCs) in the United States and Canada, as well as in eight countries in Africa, South America, Central America, the Caribbean, and Europe. WCG Biosafety’s consulting division has led laboratory and biosafety projects in more than 50 countries over three decades, assisting government, academic and private institutions in maintaining the highest level of safety, security and compliance.
The demands for biological safety are – and will continue to be – dynamic. Through their trusted partnership with WCG, our clients achieve the safe and successful management of research involving rDNA and other potentially hazardous biological vectors.

Our IBC Services Include:

  • IBC review and assessment services
  • Transitional support (internal IBC to administration to external IBC administration)
  • Clinical Trial Protocol Development for Recombinant Materials (subject to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acids)
Print Friendly, PDF & Email